$50.15
-0.62[-1.22%]
Last update: 3:26PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$50.81
0.6600[1.32%]
| Open50.560 | Close- |
| Vol / Avg.492.546K / 1.663M | Mkt Cap7.010B |
| Day Range50.100 - 50.730 | 52 Wk Range48.860 - 80.040 |
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%
Globus Medical Stock (NYSE:GMED), Key Statistics
Globus Medical Stock (NYSE: GMED) analysis, key statistics.
Valuation Measures
Enterprise Value
6.5B
Trailing P/E
25.39
Forward P/E
19.53
PE Ratio (TTM)
24.33
PEG Ratio (TTM)
1.78
Price / Sales (ttm)
4.72
Price / Book (mrq)
3.58
Price / EBITDA
16.24
Enterprise Value / EBITDA (TTM)
20.36
Earnings Yield
3.94%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
14.2
Tangible Book value per share
12.39
Total Liabilities (Quarterly)
227.4M
Total Assets
2.2B
Total Liabilities
227.4M
Profitability
Net income Growth
0.06
Gross Margin
73.78%
Net Margin
19.79%
EBIT Margin
23.72%
EBITDA Margin
29.92%
Operating Margin
23.72%